Cargando…

Single and Repeated Doses of EGb 761(®) do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects

The present drug-drug interaction study investigates whether single or repeated doses of 240 mg Ginkgo biloba extract EGb 761(®) alter the pharmacokinetics or pharmacodynamics of rivaroxaban in healthy subjects. This was a single-centre, two-period, fixed-sequence trial. In Period 1, rivaroxaban was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoerr, Robert, Zimmermann, Andrea, Seitz, Friedeborg, Dienel, Angelika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065292/ https://www.ncbi.nlm.nih.gov/pubmed/35517810 http://dx.doi.org/10.3389/fphar.2022.868843

Ejemplares similares

Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers
por: Zadoyan, G., et al.
Publicado: (2011)

Antiapoptotic Effects of EGb 761
por: Serrano-García, Norma, et al.
Publicado: (2013)

Ginkgo biloba leaf extract EGb 761(®) as a paragon of the product by process concept
por: Kulić, Žarko, et al.
Publicado: (2022)

Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
por: Hort, Jakub, et al.
Publicado: (2023)

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761(®). Findings from a randomized controlled trial
por: Bachinskaya, Natalia, et al.
Publicado: (2011)

Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine
por: Sokolova, Larysa, et al.
Publicado: (2014)

A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761(®)
por: Hoerr, Robert, et al.
Publicado: (2015)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008)

A Detailed View on the Proanthocyanidins in Ginkgo Extract EGb 761
por: Kulić, Žarko, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Ginkgo biloba extract EGb 761(®) improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial
por: Cui, Mei, et al.
Publicado: (2023)

EGb 761(®) Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer’s Dementia—Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial
por: Kloft, Charlotte, et al.
Publicado: (2021)

EGb761 protects motoneurons against avulsion-induced oxidative stress in rats
por: Cheng, Xiao, et al.
Publicado: (2010)

Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®))
por: Tomino, Carlo, et al.
Publicado: (2021)

Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects
por: Kubitza, Dagmar, et al.
Publicado: (2014)

Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
por: Li, Junfeng, et al.
Publicado: (2015)

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
por: Mueck, Wolfgang, et al.
Publicado: (2013)

The Ginkgo biloba Extract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation
por: Stark, Marcel, et al.
Publicado: (2014)

Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent
por: Wang, Yufang, et al.
Publicado: (2015)

Preventive Effects of Ginkgo-Extract EGb 761(®) on Noise Trauma-Induced Cochlear Synaptopathy
por: Tziridis, Konstantin, et al.
Publicado: (2022)

Ginkgo biloba extract EGb 761(®) alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trials
por: Spiegel, Rainer, et al.
Publicado: (2018)

Pharmacokinetic Properties of Rivaroxaban in Healthy Human Subjects
por: Bratsos, Sosipatros
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
por: Chen, Hanjing, et al.
Publicado: (2022)

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Kim, Minsoo, et al.
Publicado: (2019)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Ngo, Lien Thi, et al.
Publicado: (2020)

EGB761 ameliorates chronic cerebral hypoperfusion-induced cognitive dysfunction and synaptic plasticity impairment
por: Yao, Zhao-Hui, et al.
Publicado: (2021)

Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761(®): A Case Series
por: Zifko, Udo A., et al.
Publicado: (2022)

Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
por: Zhou, Ying, et al.
Publicado: (2018)

Protective effects of Ginkgo biloba extract (EGB 761) on astrocytes of rat hippocampus after exposure with scopolamine
por: Jahanshahi, Mehrdad, et al.
Publicado: (2012)

Ginkgo biloba extract (EGb 761) prevents the ischemic brain injury-induced decrease in parvalbumin expression
por: Sung, Jin-Hee, et al.
Publicado: (2012)

Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats
por: Saini, Arminder Singh, et al.
Publicado: (2014)

Ginkgo biloba Extract EGb 761 Improves Vestibular Compensation and Modulates Cerebral Vestibular Networks in the Rat
por: Lindner, Magdalena, et al.
Publicado: (2019)

Ginkgo biloba extract (EGb761) did not express estrogenic activity in an immature rat uterotrophic assay
por: Moon, Byeonghak, et al.
Publicado: (2018)

Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia
por: García-Alberca, José María, et al.
Publicado: (2022)

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects
por: Moore, Kenneth Todd, et al.
Publicado: (2015)

Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
por: Zhou, Ying, et al.
Publicado: (2019)

Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
por: Liu, Xiao-Qin, et al.
Publicado: (2022)

The effects of EGb761 on lipopolysaccharide-induced depressive-like behaviour in C57BL/6J mice
por: Zhao, Yuehan, et al.
Publicado: (2015)

The Protective Effect of Egb 761 Against 3-Nitropropionic Acid-Induced Hearing Loss: The Role of Sirtuin 1
por: Chang, Mun Young, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fo0r5o2rrmvpqdsuc6k0n162ff